| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1491 | $1480 | $1629 | |
| Inventory | ||||
| Total current assets | $4387 | $4355 | $4747 | |
| Long term investments | ||||
| Property, plant & equipment | $3540 | $3519 | $3538 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $10396 | $10163 | $10590 | |
| Current liabilities | ||||
| Accounts payable | $1240 | $1337 | $1408 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $4249 | $4230 | $4588 | |
| Long term debt | $3106 | $3109 | $3112 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $9331 | $9167 | $9575 | |
| Shareholders' equity | ||||
| Retained earnings | -$2351 | -$2308 | -$2319 | |
| Other shareholder equity | -$1090 | -$1192 | -$1145 | |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 1 May 2024 | 31 Jan 2023 | 31 Jan 2022 | 
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1629 | $1553 | $2341 | |
| Inventory | ||||
| Total current assets | $4747 | $4963 | $5777 | |
| Long term investments | ||||
| Property, plant & equipment | $3538 | $3743 | $4284 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $10590 | $11464 | $13213 | |
| Current liabilities | ||||
| Accounts payable | $1408 | $1774 | $1140 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $4588 | $4868 | $4544 | |
| Long term debt | $3112 | $3111 | $3128 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $9575 | $10099 | $10514 | |
| Shareholders' equity | ||||
| Retained earnings | -$2319 | -$1978 | -$375 | |
| Other shareholder equity | -$1145 | -$1062 | -$1144 | |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3774 | $3739 | $3850 | $3936 | 
| Cost of revenue | ||||
| Gross Profit | $750 | $805 | $716 | $752 | 
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $730 | $693 | $748 | $745 | 
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $38 | $53 | $41 | $65 | 
| Interest expense | -$25 | -$28 | -$30 | -$31 | 
| Net income | ||||
| Net income | -$43 | $11 | -$45 | -$12 | 
| Income (for common shares) | ||||
| (in millions $) | 1 May 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16052 | $18657 | $19352 | |
| Cost of revenue | ||||
| Gross Profit | $2863 | $2087 | $2209 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $2956 | $2850 | $3912 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $172 | $397 | $246 | |
| Interest expense | -$122 | -$64 | -$63 | |
| Net income | ||||
| Net income | -$340 | -$2319 | -$2012 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$241 | -$166 | -$553 | -$350 | 
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$101 | -$51 | -$170 | -$123 | 
| Effect of exchange rate | $17 | -$17 | -$37 | -$5 | 
| Change in cash and equivalents | -$224 | -$281 | -$306 | -$169 | 
| (in millions $) | 1 May 2024 | 1 May 2023 | 31 Jan 2022 | 31 Jan 2021 | 
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$553 | -$835 | -$572 | -$953 | 
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$170 | -$141 | $2915 | $312 | 
| Effect of exchange rate | -$37 | -$100 | -$22 | $1 | 
| Change in cash and equivalents | -$306 | -$294 | $2203 | -$13 | 
| Market cap | N/A | 
|---|---|
| Enterprise value | N/A | 
| Shares outstanding | N/A | 
| Revenue | $15.30B | 
|---|---|
| EBITDA | N/A | 
| EBIT | N/A | 
| Net Income | -$89.00M | 
| Revenue Q/Q | N/A | 
| Revenue Y/Y | N/A | 
| P/E ratio | N/A | 
|---|---|
| EV/Sales | N/A | 
| EV/EBITDA | N/A | 
| EV/EBIT | N/A | 
| P/S ratio | N/A | 
| P/B ratio | N/A | 
| Book/Share | N/A | 
| Cash/Share | N/A | 
| EPS | N/A | 
|---|---|
| ROA | N/A | 
| ROE | N/A | 
| Debt/Equity | N/A | 
|---|---|
| Net debt/EBITDA | N/A | 
| Current ratio | N/A | 
| Quick ratio | N/A |